As of 2026-10-16, the Fair Value of SQZ Biotechnologies Co (SQZ) is -13.47 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.44 USD, the upside of SQZ Biotechnologies Co is -3,197.14%.
With the market price of 0.44 USD and our fair value calculation, SQZ Biotechnologies Co (SQZ) is not a good investment. Investing in SQZ stocks now will result in a potential loss of 3,197.14%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -68.74 | -79.46 | - | - | -74.10 | |
| YoY growth | -36.06% | -15.60% | - | - | -25.83% | |
| Market Cap (mil) | 12.83 |
| P/E | |
| Forward P/E |
| EPS | -2.69 |
| Avg earnings growth rate | -25.83% |
| TTM earnings | -79.46 |